The company has started production at its first Indian factory and plans to increase capacity tenfold by 2028, while reducing reliance on Vietnam for supply.
Omron Healthcare has begun full-scale production of blood pressure monitors at its first factory in India, a site near Chennai that the company says will serve both the domestic market and, in time, overseas customers. The Japanese health equipment maker said the plant marks a significant step in its Indian manufacturing strategy, with the facility initially focused on local demand before being developed into an export base. According to Reuters, the company is also aiming to reduce its dependence on production in Vietnam as it broadens its supply chain.
The factory is located at ORIGINS by Mahindra in Tamil Nadu and covers about 24,000 square metres. It has five production lines and is operated by Omron Healthcare Manufacturing India Pvt. Ltd. The site is already making three monitor ranges: the HEM-7090, HEM-7181 and HEM-7183T. The company says the Chennai plant uses production methods and quality-control systems developed at its facilities in Japan and Vietnam, so the devices assembled in India are intended to meet the same measurement and reliability standards used for products sold internationally.
The three models target different types of users. Omron says the HEM-7090 is a basic upper-arm monitor aimed at straightforward home use, including for first-time buyers. The HEM-7181 adds a trend indicator and memory function, while the HEM-7183T includes Bluetooth connectivity for use with the OMRON Connect app and a cuff designed for easier fitting. Industry reports say the plant is also expected to support local sourcing, workforce development and job creation as part of India’s Make in India agenda.
The expansion comes against the backdrop of a large public health gap in India. Omron estimates that about 300 million people in the country live with hypertension, yet fewer than 5 per cent of households regularly use a home blood pressure monitor. The company says that widening domestic production should make home monitoring more accessible and help with earlier detection and management of cardiovascular risk. Omron has operated in India since 2010 and says it has worked with clinicians and local partners to promote awareness of hypertension, including through collaboration with the Indian Society of Hypertension on home blood pressure monitoring guidelines.
Looking ahead, Omron plans to increase the Chennai plant’s capacity tenfold by 2028. Jiji Press reported that the company aims to reach an annual output of about three million blood pressure monitors, while also building up the share of parts sourced locally instead of importing most components from Vietnam. The company says it may later add nebuliser production at the site, widening the factory’s role in its home healthcare business and strengthening supply for India and export markets alike.
Disclaimer: This content is intended for informational purposes only. Readers are advised to exercise their own judgement, conduct due diligence, or consult a qualified expert before acting on any information provided.
